Bacterial Vaginosis 

Patient Population:
Pediatric

This and other STI sections are not meant to be comprehensive references for all STI treatment but primarily focused on the most commonly used initial empiric antimicrobial therapy. Users should refer to linked resources (SFDPH City Clinic protocols, CDC guidelines) or other local resources to provide patients and their partners appropriate counseling and follow-up. For non-adolescent age patients, patients with STIs not addressed in these guidelines, or patients with contraindications to the listed therapies, we recommend referring to the linked resources, or Lexi-Comp for medication information, or consulting ID/ASP for individualized recommendations. 

Condition Major Pathogens  First Choice Therapy Alternative Therapy Comments
Bacterial vaginosis, treatment in symptomatic patients  Anaerobic bacteria 

Metronidazole
500 mg enterally bid x 7 days 

OR  

Metronidazole gel
0.75% one applicator (5 g) intravaginally at bedtime daily    

Other treatment options exist for patients with contraindications to metronidazole; refer to CDC guidelines linked below, or SFDPH City Clinic protocol linked in comments 

Refer to SFDPH City Clinic STI protocols section on bacterial vaginosis for recommended evaluation, additional STI testing, counseling (including to avoid alcohol consumption during treatment), and follow up 

Duration: 7 days for systemic treatment (enteral), 5 days for intravaginal treatment 

Reference: 

Workowski KA, et al. Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep 2021;70:1-187.